The global next generation sequencing market is anticipated to reach USD 21.4 billion by 2025, according to a new report by Grand View Research, Inc. Increasing coverage of NGS is expected to drive use of precision medicine in oncology from research based setting to clinical cancer setting. Commercial payers are also engaged in reviewing the existing and novel tests in order to establish appropriate medical necessity criteria for their clinical and medical policies.
Moreover, improved understanding of the genetic markers of virulence and resistance provided by next generation sequencing is expected to drive demand of the technology in infectious disease diagnosis. Full Research Report On Global Next Generation Sequencing Market By Grand View Research: www.grandviewresearch.com/industry-analysis/next-generation-sequencing-market Further key findings from the study suggest:
www.grandviewresearch.com/industry/biotechnology Grand View Research has segmented the NGS market on the basis of application, technology, workflow, and end use: NGS Outlook, by Application (Revenue, USD Million; 2014 - 2025)
www.grandviewresearch.com/press-release/global-next-generation-sequencing-market About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. For More Information: www.grandviewresearch.com
0 Comments
Leave a Reply. |